Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Dorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz, Lea Kiefer, Kunal Merchant, Diego Alvarado, Lawrence J. Thomas, Thomas Hawthorne, Elizabeth Crowley, Margo Heath-Chiozzi, Martin Metz, Marcus Maurer*
Untersuchen Sie die Forschungsthemen von „Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria“. Zusammen bilden sie einen einzigartigen Fingerprint.